title: Revving up the immune therapy business.
abstract: Giant pharmaceutical companies and biotech startups are seizing opportunities to advance their oncologic immunotherapy business and provide patients with more-effective treatment options.
mesh_terms: D004345:Drug Industry; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy